. IDM PHARMA INC. DL-01 WKN: A0F50C kaufen!
Seite 1 von 1 Neuester Beitrag: 08.10.12 23:34 | ||||
Eröffnet am: | 05.02.08 21:58 | von: wikki 1 | Anzahl Beiträge: | 8 |
Neuester Beitrag: | 08.10.12 23:34 | von: wikki 1 | Leser gesamt: | 4.298 |
Forum: | Börse | Leser heute: | 0 | |
Bewertet mit: | ||||
IDM Pharma to Present at 6th Annual JMP Securities Research Conference
15.05.07 14:00 (BUSINESS WIRE)
IDM Pharma Reports First Quarter 2007 Financial Results
09.05.07 19:32 (BUSINESS WIRE)
FDA Advisory Committee Reviews Data on IDM Pharma's Junovan(TM) (mifamurtide) for Treatment of Osteosarcoma
07.05.07 14:00 (BUSINESS WIRE)
IDM Pharma to Hold Post Advisory Committee Conference Call
04.05.07 14:00 (BUSINESS WIRE)
IDM Pharma Appoints Robert De Vaere as Senior Vice President and CFO
19.04.07 14:00 (BUSINESS WIRE)
IDM Pharma Appoints Edward E. Penhoet, Ph.D to Board of Directors
03.04.07 16:35 (BUSINESS WIRE)
IDM Pharma Inc. Announces Oncologic Drugs Advisory Committee Meeting for Junovan(TM) (Mifamurtide) Will Take Place on May 9, 2007
02.04.07 14:00 (BUSINESS WIRE)
IDM Pharma Reports 2006 Financial Results
28.02.07 14:00 (BUSINESS WIRE)
IDM Pharma Announces the Completion of Enrollment in Two Phase II Trials of Uvidem(R) in Melanoma
21.02.07 14:00 (BUSINESS WIRE)
IDM Pharma Raises $12.8 Million in Private Placem
Marktkapitalisierung n.a. EUR
Anzahl Aktien 25.148.000 Stk.
Streubesitz
was sagt mir das,ich kann über 80$ steigen
so hätte ich das nicht geschrieben
waren das Kinder?